Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 6, 2007, Pages

  Xiao, Zuoliang ^a   Schmitz, Frank ^b   Pricolo, Victor E ^a   Biancani, Piero ^a   Behar, Jose ^a  

^a BROWN UNIVERSITY   (United States)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Caveolin 3 proteins; Cholecystokinin 1 receptors; G protein fragments

Indexed keywords

CAVEOLIN 3; CHOLECYSTOKININ A RECEPTOR; CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; GALLBLADDER MOTILITY; HUMAN; HUMAN TISSUE; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BILE PIGMENTS; CAVEOLAE; CAVEOLIN 3; CHOLECYSTOLITHIASIS; CHOLESTEROL; GALLBLADDER; GALLSTONES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUINEA PIGS; HUMANS; LIPOSOMES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; SINCALIDE;

EID: 34447550768     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00495.2006     Document Type: Article

References (50)

1. Amaral J, Xiao ZL, Chen Q, Yu P, Biancani P, Behar J. Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology 120: 506-511, 2001.
2. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 97: 1479-1484, 1989.
3. Bergdahl A, Swärd K. Caveolae-associated signalling in smooth muscle. Can J Physiol Pharmacol 82: 289-299, 2004.
4. Bialechi RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol Cell Physiol 257: C306-C314, 1989.
5. Chattopadhyay A, Jafurulla M, Kalipatnapu S, Pucadyil TJ, Harikumar KG. Role of cholesterol in ligand binding and G-protein coupling of serotonin1A receptors solubilized from bovine hippocampus. Biochem Biophys Res Commun 327: 1036-1041, 2005.
6. Chen Q, Amaral J, Biancani P, Behar J. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology 116: 678-685, 1999.
7. Chen Q, Amaral J, Oh S, Biancani P, Behar J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 113: 930-937, 1997.
8. Chen Q, Chitinavis V, Xiao ZL, Yu P, Oh S, Biancani P, Behar J. Impaired G protein function in gallbladder muscle from progesterone treated guinea pigs. Am J Physiol Gastrointest Liver Physiol 274: G283-G289, 1998.
9. Chen Q, Lee K, Xiao Z, Biancani P, Behar J. Mechanism of gallbladder relaxation in the cat: role of norepinephrine. J Pharmacol Exp Ther 285: 475-479, 1998.
10. Chen Q, Petris GD, Yu P, Amaral J, Biancani P, Behar J. Different pathways mediate cholecystokinin actions in cholelithiasis. Am J Physiol Gastrointest Liver Physiol 272: G838-G844, 1997.
11. q-11 protein expression in guinea pig antral and colonic circular muscle during pregnancy. Am J Physiol Gastrointest Liver Physiol 276: G895-G900, 1999.
12. Dessy C, Kelly RA, Balligand JL, Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 19: 4272-4280, 2000.
13. Dodds WJ, Hogan WJ, Geenen JE. Motility of the Biliary System. Baltimore, MD: Waverly, 1989. p. 1055-1101.
14. Fielding CJ. Caveolae and signaling. Curr Opin Lipidol 12: 281-287, 2001.
15. Fielding CJ, Bist A, Fielding PE. Caveolin mRNA levels are upregulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94: 3753-8, 1997.
16. Fielding CJ, Fielding PE. Cholesterol and caveolae: structural and functional relationships. Biochim Biophys Acta 1529: 210-222, 2000.
17. Fielding CJ, Fielding PE. Intracellular cholesterol transport. J Lipid Res 38: 1503-1521, 1997.
18. Fielding CJ, Fielding PE. Relationship between cholesterol trafficking and signaling in rafts and caveolae. Biochim Biophys Acta 1610: 219-228, 2003.
19. Kawamura S, Miyamoto S, Brown JH. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem 278: 31111-31117, 2003.
20. s in lung membranes. J Biol Chem 267: 3382-3388, 1992.
21. Klein I, Moore L, Pastan I. Effect of liposomes containing cholesterol on adenylate cyclase activity of cultured mammalian fibroblasts. Biochim Biophys Acta 506: 42-53, 1978.
22. Koga A, Oka N, Kikuchi T, Miyazaki H, Kato S, Imaizumi T. Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 42: 213-219, 2003.
23. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimot I, Lisanti MP. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701, 1995.
24. Matsumoto T, Sarna SK, Condon RE, Dodds WJ, Mochinaga N. Canine gallbladder cyclic motor activity. Am J Physiol Gastrointest Liver Physiol 255: G409-G416, 1988.
25. Munson PJ, Rodbard D. Ligand, a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107: 220-239, 1980.
26. i-2. Am J Physiol Cell Physiol 279: C925-C934, 2000.
27. Murthy KS, Makhlouf GM. Heterologous desensitization mediated by G protein-specific binding to caveolin. J Biol Chem 275: 30211-30219, 2000.
28. Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol 161: 673-677, 2003.
29. Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci 113: 2103-2109, 2000.
30. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
31. Roslyn JJ, DenBesten L, Thompson JEJ, Silverman BF. Roles of lithogenic bile and cystic duct occlusion in the pathogenesis of acute cholecystitis. Am J Surg 140: 126-130, 1980.
32. Schmitz F, Goke MN, Otte JM, Schrader H, Reimann B, Kruse ML, Siegel EG, Peters J, Herzig KH, Folsch UR, Schmidt WE. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul Pept 102: 101-110, 2001.
33. 3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data. J Pharmacol Exp Ther 286: 1094-1102, 1998.
34. Shaw MJ, Hadac EM, Miller LJ. Preparation of enriched plasma membrane from bovine gallbladder muscularis for characterization of cholecystokinin receptors. J Biol Chem 29: 14313-14318, 1987.
35. Smart EJ, Ying YS, Mineo C, Anderson RG. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92: 10104-10108, 1995.
36. Smith RD, Babiychuk EB, Noble K, Draeger A, Wray S. Increased cholesterol decreases uterine activity: functional effects of cholesterol alteration in pregnant rat myometrium. Am J Physiol Cell Physiol 288: C982-C988, 2005.
37. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261, 1996.
38. Tarasova NI, Stauber RH, Choi JK, Hudson EA, Czerwinski G, Miller JL, Pavlakis GN, Michejda CJ, Wank SA. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem 272: 14817-14824, 1997.
39. Toselli M, Taglietti V, Parente V, Flati S, Pavan A, Guzzi F, Parenti M. Attenuation of G protein-mediated inhibition of N-type calcium currents by expression of caveolins in mammalian NG108-15 cells. J Physiol 536: 361-373, 2001.
40. Uittenbogaard A, Ying Y, Smart EJ. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J Biol Chem 273: 6525-6532, 1998.
41. 2 on gallbladder muscle cytoprotection of guinea pigs. Am J Physiol Gastrointest Liver Physiol 286: G82-G88, 2004.
42. Xiao ZL, Chen Q, Amaral J, Biancani P, Behar J. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Am J Physiol Gastrointest Liver Physiol 278: G251-G258, 2000.
43. Xiao ZL, Chen Q, Amaral J, Biancani P, Jensen RT, Behar J. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol Gastrointest Liver Physiol 276: G1401-G1407, 1999.
44. Xiao ZL, Chen Q, Biancani P, Behar J. Abnormalities of the gallbladder muscle cell membrane associated with acute cholecystitis in guinea pigs. Am J Physiol Gastrointest Liver Physiol 281: G490-G497, 2001.
45. Xiao ZL, Chen Q, Biancani P, Behar J. Mechanisms of gallbladder hypomotility in pregnant guinea pigs. Gastroenterology 116: 411-419, 1999.
46. 2): effects on the gallbladder muscle of guinea pigs. Am J Physiol Gastrointest Liver Physiol 282: G300-G306, 2002.
47. Xiao ZL, Rho AK, Biancani P, Behar J. Effects of bile acids on the muscle functions of guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 283: G87-G94, 2002.
48. Xiao ZL, Schmitz F, Biancani P, Behar J. Role of caveolin-3 proteins in the cholesterol induced impaired human gallbladder contraction in response to CCK-8 (Abstract). Gastroenterology 126 (Suppl 2): A40, 2004.
49. Yu P, Chen Q, Biancani P, Behar J. Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am J Physiol Gastrointest Liver Physiol 271: G56-G61, 1996.
50. Yu P, Chen Q, Harnett KM, Amaral J, Biancani P, Behar J. Direct G protein activation reverses impaired CCK-signaling in human gallbladders with cholesterol stones. Am J Physiol Gastrointest Liver Physiol 269: G659-G665, 1995.